Xynomic Pharmaceuticals (XYNPW) S-1/A IPO registration (amended)

Exhibit 99.4

CONSENT OF DIRECTOR NOMINEE

As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named as a Director Nominee in the Registration Statement on Form S-1 of Bison Capital Acquisition Corp. (the “Company”), confidentially submitted on April 18, 2017, and any and all amendments thereto, registering securities for issuance in the Company’s initial public offering.

Dated: April 18, 2017	/s/ Thomas Folinsbee
	Thomas Folinsbee